HER2-low Unresectable and/or Metastatic Breast Cancer in Russia
Phase
N/ASpan
96 weeksSponsor
AstraZenecaIstra
Recruiting
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
Phase
N/ASpan
170 weeksSponsor
AstraZenecaIstra
Recruiting
1-2 of 2